In re Guidant Life-Link Products Liability Litigation Lawsuit

In re Guidant Life-Link Products Liability Litigation

Product and manufacturer

Guidant Corporation was an American medical device company headquartered in Indianapolis, Indiana, whose product line centered on the heart. The company designed implantable cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), and coronary and peripheral stents. Its history traces back to Cardiac Pacemakers, Inc., a start-up founded in St. Paul, Minnesota in 1972; that business passed through Eli Lilly before the medical devices division was spun off and listed under the name Guidant in 1994. The "Life-Link" in the case name refers to Guidant's pacemaker and ICD line. The two device types served different clinical roles: a pacemaker sustains a heart's electrical rhythm, while an ICD is built to detect life-threatening arrhythmias and deliver a corrective shock. Both are implanted and expected to function reliably for years, which is why failures carry severe consequences for the patients who depend on them.

Alleged harm

The problems emerged in public in 2005. In May of that year Guidant reported a batch of ICD failures, one of which was fatal, and contemporaneous press reporting accused the company of taking years to tell physicians about the defects. Subsequent safety notices widened the circle of affected models, covering several ICD lines and then multiple generations of pacemakers. In September 2005 Guidant issued safety advisories and a recall covering roughly 170 thousand Life-Link pacemakers and ICDs. The core concern was the leads — the thin insulated wires that run from the implanted pulse generator into the heart and carry its electrical signals. The allegation at the heart of the litigation was that these leads could fracture over time, leaving a device unable to pace correctly or unable to deliver the therapy its implant was meant to provide. Patients who had received the affected devices, and in some cases the estates of those who did not survive device failure, brought product liability suits.

Litigation

The federal cases were centralized as Multi-District Litigation No. 05-1708 (DWF/AJB) in the United States District Court for the District of Minnesota, before Judge Donovan W. Frank, as reflected in the court's 2007 docket orders. Centralization placed the dispersed state and federal claims into a single forum for coordinated discovery and pretrial rulings, the usual structure for a device-failure case cluster of this kind.

The litigation ran through a period of unusual turbulence in the company's corporate life. Johnson & Johnson had announced its intent to buy Guidant in late 2004, but the 2005 device failures and the regulatory scrutiny that followed led to a renegotiated price and then an open bidding contest with Boston Scientific. Boston Scientific's offer ultimately prevailed and the merger closed in April 2006. Johnson & Johnson later completed its own acquisition of Boston Scientific in December 2006, which is why the corporate record generally shows Guidant passing into the Johnson & Johnson group at that point. The identity of the defendant in the ongoing litigation thus shifted with these transactions, a complication that the centralized docket had to manage alongside the merits questions.

Outcome

The primary sources assembled for this archive entry do not confirm a final outcome for MDL 05-1708. No termination date, resolution year, or outcome category is recorded in the case data, so this entry does not state how or when the litigation concluded. Researchers following the docket should consult the court's filings directly for the current posture.

This is an archived encyclopedia record; intake for new claims is closed and the entry is provided for historical reference only.